9 Recruiting Studies Using Navitoclax
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Navitoclax
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis
📍 Ironwood Cancer & Res Ctr /ID# 222162 — Chandler, Arizona
Myelofibrosis (MF)
View Study & Checklist ➔Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
📍 City of Hope Medical Center — Duarte, California
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
📍 City of Hope /ID# 239769 — Duarte, California
Myeloproliferative Neoplasm
View Study & Checklist ➔Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Metastatic Malignant Solid Neoplasm
View Study & Checklist ➔Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
📍 University of California, Davis Comprehensive Cancer Center /ID# 221790 — Sacramento, California
Myelofibrosis (MF)
View Study & Checklist ➔Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
📍 Brigham and Women's Hospital — Boston, Massachusetts
Myeloid Malignancy
View Study & Checklist ➔Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Clinical Stage III Cutaneous Melanoma AJCC v8
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
📍 Sunnybrook Research Institute/Odette Cancer Centre — Toronto, Ontario
High Grade Serous Carcinoma
View Study & Checklist ➔